Evidence map›Paper›PMID 37492959›Full record

ArticleCirculation. Cardiovascular quality and outcomes2023

Patients' Perspectives Regarding Generator Exchanges of Implantable Cardioverter Defibrillators.

Sarah C Montembeau, Faisal M Merchant, Candace Speight, Daniel B Kramer, Daniel D Matlock, Michal Horný, Neal W Dickert, Birju R Rao

Abstract read
In one paragraph

Article in Circulation. Cardiovascular quality and outcomes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Sarah C MontembeauDepartment of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, GA (S.C.M., F.M.M., C.S., N.W.D., B.R.R.).ORCID 0009-0003-4452-1756
Faisal M MerchantDepartment of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, GA (S.C.M., F.M.M., C.S., N.W.D., B.R.R.).ORCID 0000-0003-0679-860X
Candace SpeightDepartment of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, GA (S.C.M., F.M.M., C.S., N.W.D., B.R.R.).
Daniel B KramerThe Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (D.B.K.).ORCID 0000-0003-4241-3586
Daniel D MatlockDepartment of Medicine, University of Colorado School of Medicine, Aurora, CO (DDM).ORCID 0000-0001-9597-9642
Michal HornýDepartment of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, GA (MH).ORCID 0000-0003-3624-6398
Neal W DickertDepartment of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, GA (S.C.M., F.M.M., C.S., N.W.D., B.R.R.).ORCID 0000-0003-4415-3861
Birju R RaoDepartment of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, GA (S.C.M., F.M.M., C.S., N.W.D., B.R.R.).ORCID 0000-0002-7593-8533

Funding

Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
J: NRSA Training CoreTL1TR002382 · NCATS · EMORY UNIVERSITY · PI HENRY M BLUMBERG, Vasiliki Michopoulos · 2017 to 2026
$8.5M
The Trajectories and Clinical Experiences of ICD Therapy (TRACER-ICD) StudyR01AG068141 · NIA · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KRAMER, DANIEL BRUCE · 2021 to 2025
$3.4M
Prospective Investigation of Palliative and End-of-Life ExpeRiences with ICDs (PIPER-ICD) StudyR01HL161697 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KRAMER, DANIEL BRUCE · 2022 to 2025
$3.0M
Understanding Patients Decisions About Generator Exchanges for Implantable DefibrillatorsF32HS028558 · AHRQ · EMORY UNIVERSITY · PI RAO, BIRJU · 2021 to 2021
$70k
AHRQ HHS F32 HS028558NCATS NIH HHS TL1 TR002382NCATS NIH HHS UL1 TR002378NHLBI NIH HHS R01 HL161697NIA NIH HHS R01 AG068141
6 · The paper itself

Abstract

backgroundShared decision-making is mandated for patients receiving primary prevention implantable cardioverter defibrillators (ICDs). Less attention has been paid to generator exchange decisions, although at the time of generator exchange, patients' risk of sudden cardiac death, risk of procedural complications, quality of life, or prognosis may have changed. This study was designed to explore how patients make ICD generator exchange decisions.

methodsEmory Healthcare patients with primary prevention ICDs implanted from 2013 to 2021 were recruited to complete in-depth interviews exploring perspectives regarding generator exchanges. Interviews were conducted in 2021. Transcribed interviews were qualitatively coded using multilevel template analytic methods. To investigate benefit thresholds for pursuing generator exchanges, patients were presented standard-gamble type hypothetical scenarios where their ICD battery was depleted but their 5-year risk of sudden cardiac death at that time varied (10%, 5%, and 1%).

resultsFifty patients were interviewed; 18 had a prior generator exchange, 16 had received ICD therapy, and 17 had improved left ventricular ejection fraction. As sudden cardiac death risk decreased from 10% to 5% to 1%, the number of participants willing to undergo a generator exchange decreased from 48 to 42 to 33, respectively. Responses suggest that doctor's recommendations are likely to substantially impact patients' decision-making. Other drivers of decision-making included past experiences with ICD therapy and device implantation, as well as risk aversion. Therapeutic inertia and misconceptions about ICD therapy were common and represent substantive barriers to effective shared decision-making in this context.

conclusionsStrong defaults may exist to continue therapy and exchange ICD generators. Updated risk stratification may facilitate shared decision-making and reduce generator exchanges in very low-risk patients, especially if these interventions are directed toward clinicians. Interventions targeting phenomena such as therapeutic inertia may be more impactful and warrant exploration in randomized trials.

Indexed as

Defibrillators, ImplantableDeath, Sudden, CardiacHumansPrimary PreventionQuality of LifeRisk FactorsStroke VolumeVentricular Function, Leftbenefit-risk assessmentcardioverter defibrillatorsclinical decision-making implantablepatient preferencesudden cardiac death

Identifiers

PMID37492959
PMCPMC10524607

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.